Colombia vs Guyana: Cause of death, by non-communicable diseases, ages 5-14
Colombia
43.6%
in 2021
Guyana
43.9%
in 2021
Colombia rank
68th
Guyana rank
67th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Colombia
- Guyana
How they compare
Guyana currently reports 43.9% against 43.6% in Colombia, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Guyana ahead.
Colombia ranks 68th and Guyana ranks 67th of 185 countries.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.4% | 35.2% | 4.9% | Guyana |
| 2010s | 39.5% | 40.9% | 1.4% | Guyana |
| 2020s | 44.8% | 45.3% | 0.5% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Colombia or Guyana?
- Guyana, at 43.9% against 43.6% in Colombia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Colombia and Guyana?
- 0.3%, with Guyana ahead.
- How many years of comparable data are there for Colombia and Guyana?
- 6 years are reported by both, from 2000 to 2021.
- How do Colombia and Guyana rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Colombia ranks 68th and Guyana ranks 67th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.